Journal of Cataract & Refractive Surgery
Volume 34, Issue 9 , Pages 1451-1459, September 2008

Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery

From a private practice and the University of Minnesota School of Medicine (Lane), Stillwater, Minnesota; a private practice and the University of Cincinnati (Osher), Cincinnati, Ohio; UCLA Geffen School of Medicine (Masket), and a private practice (Masket, Belani), Los Angeles, California, USA

Accepted 16 May 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Drs. Lane, Osher, and Masket are consultants to Alcon Laboratories, Inc. Dr. Belani received a grant to support this research. Susanne Gardner was the medical writter, and Jenny Song provided the statistical analysis.

 Funded by a grant from Alcon Laboratories, Inc.

PII: S0886-3350(08)00630-5

doi:10.1016/j.jcrs.2008.05.034

Journal of Cataract & Refractive Surgery
Volume 34, Issue 9 , Pages 1451-1459, September 2008

Article Tools

* Image Usage & Resolution